← All themes

GLP-1 & Obesity

GLP-1 medicines treat obesity and diabetes, and have grown into one of the largest drug categories ever launched. Their reach extends past medicine, because a change in how much people eat moves whole consumer industries.

92 stocks

Obesity Second-Order Effects

Funds Holding in Top 10 Value Capital Flow New & Closed Increased & Reduced Calls & Puts Put/Call Ratio

New

Increased

Maintained

Reduced

Closed

Funds Holding 4,507

Funds Holding Change +273

Funds Holding Growth +6%

Value $944B

Holding in Top 10 746

Top 10 Change +71

Top 10 Growth +11%

Value Growth +12%

New 474

Increased 1,827

Reduced 1,915

Closed 114

Capital Inflow $29.7B

Capital Outflow $25.6B

Net Capital Flow +$4.16B

Capital Flow Change +$3.09B

Calls $11.7B

Puts $11.8B

Net Calls -$108M

Put/Call Ratio 1.01